Reduction in Drinking was Associated With Improved Clinical Outcomes in Women With HIV Infection and Unhealthy Alcohol Use: Results From a Randomized Clinical Trial of Oral Naltrexone Versus Placebo

Alcoholism, Clinical and Experimental Research
Robert L CookKendall Bryant

Abstract

Alcohol consumption is associated with poor health outcomes in women living with HIV (WLWH), but whether medication can help to reduce drinking in non-treatment-seeking women or whether reduction in drinking improves HIV outcomes is unclear. We conducted a randomized clinical trial (RCT) of daily oral naltrexone (50 mg) versus placebo in WLWH who met criteria for current unhealthy alcohol use. WLWH with current unhealthy alcohol use (>7 drinks/wk or >3 drinks/occasion) were randomly assigned to daily oral naltrexone 50 mg (n = 96) or placebo (n = 98) for 4 months. Drinking outcomes, including the proportion of women who reduced (<unhealthy use criteria) or quit drinking, were assessed at baseline, 2 months, 4 months (end of treatment), and 7 months. In a secondary analysis, HIV viral suppression and changes in CD4 counts were compared in women who did or did not reduce/quit drinking, regardless of intervention assignment. The participants' mean age was 48 years, 86% were African American, and 94% were receiving HIV antiretroviral therapy. Among all participants, 89% and 85% completed the 4-month and 7-month follow-ups, respectively. Participants in both groups substantially reduced drinking over time. At 1 and 3 months, naltrex...Continue Reading

References

Oct 15, 2005·Journal of Studies on Alcohol. Supplement·Bankole A JohnsonJohn D Roache
Apr 21, 2006·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Steina AradottirChrister Alling
Apr 21, 2006·American Journal of Epidemiology·M Alan BrookhartTil Stürmer
Aug 10, 2006·AIDS and Behavior·K P TheallP Kissinger
Feb 23, 2010·Lancet·Damien G FinnissFabrizio Benedetti
Sep 4, 2010·Current HIV/AIDS Reports·Judith A Hahn, Jeffrey H Samet
Mar 5, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mariam Aziz, Kimberly Y Smith
Sep 17, 2011·Gastroenterology·Bin Gao, Ramon Bataller
Jun 13, 2012·AIDS Patient Care and STDs·Jayraan BadieeUNKNOWN Hiv Neurobehavioral Research Program (HNRP) Group
Jul 28, 2012·AIDS and Behavior·Robert L CookMardge H Cohen
Jul 31, 2013·Alcoholism, Clinical and Experimental Research·Raye Z LittenHsiao-ye Yi
May 16, 2014·JAMA : the Journal of the American Medical Association·Daniel E JonasJames C Garbutt
Dec 3, 2014·AIDS Patient Care and STDs·Hrishikesh ChakrabortySharon Weissman
Feb 10, 2016·Drug and Alcohol Dependence·Geetanjali ChanderMary E McCaul
Feb 27, 2016·Alcoholism, Clinical and Experimental Research·Robert G DeissGrace E Macalino
Mar 30, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Julia M A SinclairDavid S Baldwin
Mar 2, 2017·Alcoholism, Clinical and Experimental Research·Shantrel S CanidateRobert L Cook
Dec 28, 2017·Alcoholism, Clinical and Experimental Research·Kelly E MooreMichael D Stein
Sep 1, 2018·JAMA : the Journal of the American Medical Association·Henry R Kranzler, Michael Soyka

❮ Previous
Next ❯

Citations

Apr 22, 2020·Current HIV/AIDS Reports·Natalie E ChichettoMatthew S Freiberg
Dec 10, 2020·Alcoholism, Clinical and Experimental Research·Mark K BrittonRonald A Cohen
Mar 27, 2021·Substance Use & Misuse·Rebecca J FiskRobert L Cook
Jun 11, 2021·Current HIV/AIDS Reports·Wendee M WechsbergIsa van der Drift

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.